Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules (Q46932015)

26 December 2017

title

Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules (English)

1 reference

26 December 2017

0 references

1 reference

Robert P Lisak

1

1 reference

26 December 2017

Liljana Nedelkoska

series ordinal

2

1 reference

26 December 2017

Joyce A Benjamins

series ordinal

3

1 reference

26 December 2017

publication date

13 February 2014

1 reference

26 December 2017

published in

Glia

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

751-762

1 reference

26 December 2017

Nitric oxide as an activity marker in multiple sclerosis

cites work

1 reference

A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis

21 January 2018

1 reference

Excitotoxic neuronal cell death in amyotrophic lateral sclerosis

21 January 2018

1 reference

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

21 January 2018

1 reference

Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway

21 January 2018

1 reference

Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development

21 January 2018

1 reference

Neurodegenerative diseases and oxidative stress

21 January 2018

1 reference

ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro

21 January 2018

1 reference

Induction of a Common Pathway of Apoptosis by Staurosporine

21 January 2018

1 reference

Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice

21 January 2018

1 reference

Signal transduction pathways involved in interaction of galactosylceramide/sulfatide-containing liposomes with cultured oligodendrocytes and requirement for myelin basic protein and glycosphingolipids

21 January 2018

1 reference

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

21 January 2018

1 reference

Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology

21 January 2018

1 reference

Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers

21 January 2018

1 reference

Oligodendrocyte killing by quinolinic acid in vitro

21 January 2018

1 reference

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord

21 January 2018

1 reference

Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats

21 January 2018

1 reference

NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination

21 January 2018

1 reference

Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes

21 January 2018

1 reference

NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury

21 January 2018

1 reference

Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor

21 January 2018

1 reference

Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels.

21 January 2018

1 reference

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity

21 January 2018

1 reference

Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.

21 January 2018

1 reference

Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems

21 January 2018

1 reference

Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Sigma receptors: biology and therapeutic potential

21 January 2018

1 reference

Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development

21 January 2018

1 reference

Oxidative damage in multiple sclerosis lesions

21 January 2018

1 reference

Sigma receptors suppress multiple aspects of microglial activation

21 January 2018

1 reference

Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation

21 January 2018

1 reference

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2 ) signaling and cell survival

21 January 2018

1 reference

The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones

21 January 2018

1 reference

Local nitric oxide production in viral and autoimmune diseases of the central nervous system

21 January 2018

1 reference

Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain

21 January 2018

1 reference

The sigma-1 receptor: roles in neuronal plasticity and disease

21 January 2018

1 reference

Dextromethorphan ameliorates effects of neonatal hypoxia on brain morphology and seizure threshold in rats

21 January 2018

1 reference

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

Oligodendroglia metabolically support axons and contribute to neurodegeneration.

21 January 2018

1 reference

A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination

21 January 2018

1 reference

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures

21 January 2018

1 reference

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins

21 January 2018

1 reference

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures

21 January 2018

1 reference

Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro

21 January 2018

1 reference

Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

21 January 2018

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

Oligodendroglia: new players in amyotrophic lateral sclerosis

21 January 2018

1 reference

Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.

21 January 2018

1 reference

Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil

21 January 2018

1 reference

Influence of concomitant quinidine administration on dextromethorphan disposition in rats

21 January 2018

1 reference

The pharmacology of sigma-1 receptors

21 January 2018

1 reference

Selectivity of excitotoxic mechanisms in Alzheimer's disease

21 January 2018

1 reference

Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect

21 January 2018

1 reference

Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors

21 January 2018

1 reference

Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes

21 January 2018

1 reference

Glutamate receptor expression in multiple sclerosis lesions

21 January 2018

1 reference

Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system.

21 January 2018

1 reference

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

21 January 2018

1 reference

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis

21 January 2018

1 reference

Current Concepts in the Pharmacotherapy of Pseudobulbar Affect

21 January 2018

1 reference

Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect

21 January 2018

1 reference

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis

21 January 2018

1 reference

Platelet-derived growth factor in central nervous system gliogenesis

21 January 2018

1 reference

Dextromethorphan/quinidine sulfate for pseudobulbar affect

21 January 2018

1 reference

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

21 January 2018

1 reference

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

21 January 2018

1 reference

Sigma-1 receptor knockout impairs neurogenesis in dentate gyrus of adult hippocampus via down-regulation of NMDA receptors

21 January 2018

1 reference

Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain.

21 January 2018

1 reference

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system

21 January 2018

1 reference

Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction

21 January 2018

1 reference

MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity

21 January 2018

1 reference

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

21 January 2018

1 reference

Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action

21 January 2018

1 reference

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

Inducible nitric oxide synthase gene expression in the brain during systemic inflammation

21 January 2018

1 reference

Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6.

21 January 2018

1 reference

Apoptosis in multiple sclerosis

21 January 2018

1 reference

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

21 January 2018

1 reference

7 January 2021

A controlled one-year trial of dextromethorphan in amyotrophic lateral sclerosis.

1 reference

7 January 2021

Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures

1 reference

7 January 2021

Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation

1 reference

7 January 2021

A clinical trial of dextromethorphan in amyotrophic lateral sclerosis

1 reference

7 January 2021

High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies

1 reference

7 January 2021

Remyelination in multiple sclerosis

1 reference

7 January 2021

Dextromethorphan attenuates hypoxia-induced neuronal dysfunction in rat neocortical slices

1 reference

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

7 January 2021

Establishment of Schwann cell cultures from adult rat peripheral nerves

1 reference

7 January 2021

Nitric oxide and the axonal death cascade

1 reference

7 January 2021

An absence of changes in sigma receptor subtypes in the brains of genetically dystonic (dt) rats

1 reference

7 January 2021

Identifiers

DOI

10.1002/GLIA.22639

1 reference

26 December 2017

1 reference

26 December 2017